Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myopia Control in the Pediatric Population
NCT05815784Phase 2Active, not recruiting
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- May 2023
- Primary completion
- Jan 2028
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NVK002 in myopia, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started May 2023; status: active, not recruiting.
02
Drugs
NVK002
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05815784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05815784.